Gulhane School of Medicine
sbu.edu.trTotal trials
67
Active
8
Phase 3
0
Total enrollment
21,088
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Diabetes Mellitus5
- Hypogonadism4
- Proteinuria4
- Idiopathic Hypogonadotropic Hypogonadism4
- Catheter Blockage3
- Chronic Kidney Disease3
- Women2
- Urinary Incontinence (UI)2
Frequently asked questions about Gulhane School of Medicine
- How many clinical trials does Gulhane School of Medicine have on ClinicalTrials.gov?
- Gulhane School of Medicine is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Gulhane School of Medicine's trials are in Phase 3?
- 0 of Gulhane School of Medicine's trials are in Phase 3.
- What therapeutic areas does Gulhane School of Medicine focus on?
- Gulhane School of Medicine's most-studied conditions on ClinicalTrials.gov are Diabetes Mellitus, Hypogonadism, Proteinuria, Idiopathic Hypogonadotropic Hypogonadism, Catheter Blockage.